Predictive Value of Retinal Morphology for Visual Acuity Outcomes of Different Ranibizumab Treatment Regimens for Neovascular AMD
- 18 October 2015
- journal article
- research article
- Published by Elsevier BV in Ophthalmology
- Vol. 123 (1), 60-69
- https://doi.org/10.1016/j.ophtha.2015.09.013
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE StudyOphthalmology, 2011
- Effects of Vitreomacular Adhesion on Anti-Vascular Endothelial Growth Factor Treatment for Exudative Age-Related Macular DegenerationOphthalmology, 2011
- Evaluation of optical coherence tomography findings in age-related macular degeneration: a reproducibility study of two independent reading centresBritish Journal of Ophthalmology, 2010
- Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trialsBritish Journal of Ophthalmology, 2009
- Evaluation of Ranibizumab-Induced Changes in High-Resolution Optical Coherence Tomographic Retinal Morphology and Their Impact on Visual FunctionInvestigative Ophthalmology & Visual Science, 2009
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR StudyOphthalmology, 2009
- Optical coherence tomography of the retina and optic nerve – a reviewClinical & Experimental Ophthalmology, 2009
- The Role of Abnormal Vitreomacular Adhesion in Age-related Macular Degeneration: Spectral Optical Coherence Tomography and Surgical ResultsAmerican Journal of Ophthalmology, 2008
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationThe New England Journal of Medicine, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationThe New England Journal of Medicine, 2006